Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to PI-Sparing Regimens in HIV (ACTG A5103)
NCT00021463Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abacavir, nevirapine, efavirenz in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
abacavirnevirapineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00021463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021463.